These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2095128)

  • 1. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
    Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M
    Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thieno[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2-dihydrogenated homologues: synthesis, enhanced in vitro antiaggregant activity for reduced compounds.
    Gravier D; Hou G; Casadebaig F; Dupin JP; Bernard H; Boisseau M
    Pharmazie; 1992 Oct; 47(10):754-7. PubMed ID: 1480651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
    Roma G; Di Braccio M; Leoncini G; Aprile B
    Farmaco; 1993 Sep; 48(9):1225-38. PubMed ID: 8259980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
    Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A
    Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
    Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrido[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2,3,4-tetrahydro- pyrido[2,3-d]pyrimidine derivatives: synthesis and in vitro study of their activity against platelet aggregation.
    Hou G; Gravier D; Casadebaig F; Dupin JP; Bernard H; Boisseau M
    Pharmazie; 1995 Nov; 50(11):719-22. PubMed ID: 8570668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some substituted imidazo[1,2-b] [1,2,4]triazines and 8H-pyrimido[1,2-b] [1,2,4]triazin-8-ones as potential antineoplastic agents.
    Labouta IM; Soliman FS; Kassem MG
    Pharmazie; 1986 Nov; 41(11):812-3. PubMed ID: 3562515
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and 3 alpha-hydroxysteroid dehydrogenase inhibitory activity of some N(6)-(pyrazol-5-yl)-pyr-azolo[4,3-d]pyrimidin-7-ones.
    Migliara O; Plescia S; Schillaci D
    Pharmazie; 1996 Dec; 51(12):983-4. PubMed ID: 8985986
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
    El-Gazzar AR; Hafez HN
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3392-7. PubMed ID: 19481936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4,3-d]pyrimidin-5-ones.
    Bruno O; Brullo C; Schenone S; Bondavalli F; Ranise A; Tognolini M; Impicciatore M; Ballabeni V; Barocelli E
    Bioorg Med Chem; 2006 Jan; 14(1):121-30. PubMed ID: 16154749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
    Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
    Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Plescia S; Cusimano MG
    Arch Pharm (Weinheim); 2009 Jun; 342(6):321-6. PubMed ID: 19479756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa.
    Fevig JM; Cacciola J; Buriak J; Rossi KA; Knabb RM; Luettgen JM; Wong PC; Bai SA; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3755-60. PubMed ID: 16682200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and platelet aggregation inhibitory effects of N-[(1H-pyrazol-1-yl)alkyl]benzoylamides.
    Ferroni R; Milani L; Simoni D; Orlandini P; Bottura M; Bardi A; Guarneri M
    Arzneimittelforschung; 1990 Jun; 40(6):705-9. PubMed ID: 2397007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.
    Lenzi O; Colotta V; Catarzi D; Varano F; Poli D; Filacchioni G; Varani K; Vincenzi F; Borea PA; Paoletta S; Morizzo E; Moro S
    J Med Chem; 2009 Dec; 52(23):7640-52. PubMed ID: 19743865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa.
    Li YL; Fevig JM; Cacciola J; Buriak J; Rossi KA; Jona J; Knabb RM; Luettgen JM; Wong PC; Bai SA; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5176-82. PubMed ID: 16870435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic guanidines. 14. Imidazo[1,2-a]thienopyrimidin-2-one derivatives as blood platelet aggregation inhibitors.
    Ishikawa F; Kosasayama A; Yamaguchi H; Watanabe Y; Saegusa J; Shibamura S; Sakuma K; Ashida S; Abiko Y
    J Med Chem; 1981 Apr; 24(4):376-82. PubMed ID: 7265124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 2,3-substituted 4,7-dihydro-6-(1'H-pyrazol-3'-yl)pyrazolo[1,5-a] pyrimidin-7-ones and related compounds: synthesis and benzodiazepine receptor binding study.
    Selleri S; Bruni F; Costanzo A; Guerrini G; Casilli ML; Giusti L; Lucacchini A; Martini C
    Farmaco; 1995 Oct; 50(10):679-87. PubMed ID: 8590575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.